PPP3CA
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (PP2BA) is a protein that in humans is encoded by the PPP3CA gene.[1][2]
References
- ↑ Universal protein resource accession number Q08209 for “Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform” at UniProt.
- ↑ “Entrez Gene: Protein phosphatase 3, catalytic subunit, alpha isozyme”. Retrieved 2011-12-18.
Further reading
- Crabtree GR (March 1999). “Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT”. Cell. 96 (5): 611–4. doi:10.1016/S0092-8674(00)80571-1. PMID 10089876.
- Wang HG, Pathan N, Ethell IM, Krajewski S, Yamaguchi Y, Shibasaki F, McKeon F, Bobo T, Franke TF, Reed JC (April 1999). “Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD”. Science. 284 (5412): 339–43. doi:10.1126/science.284.5412.339. PMID 10195903.
- Fuentes JJ, Genescà L, Kingsbury TJ, Cunningham KW, Pérez-Riba M, Estivill X, de la Luna S (July 2000). “DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways”. Human Molecular Genetics. 9 (11): 1681–90. doi:10.1093/hmg/9.11.1681. PMID 10861295.
- Frey N, Richardson JA, Olson EN (December 2000). “Calsarcins, a novel family of sarcomeric calcineurin-binding proteins”. Proceedings of the National Academy of Sciences of the United States of America. 97 (26): 14632–7. doi:10.1073/pnas.260501097. PMC 18970. PMID 11114196.
- Siddiq A, Miyazaki T, Takagishi Y, Kanou Y, Hayasaka S, Inouye M, Seo H, Murata Y (May 2001). “Expression of ZAKI-4 messenger ribonucleic acid in the brain during rat development and the effect of hypothyroidism”. Endocrinology. 142 (5): 1752–9. doi:10.1210/en.142.5.1752. PMID 11316738.
- Graef IA, Chen F, Chen L, Kuo A, Crabtree GR (June 2001). “Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature”. Cell. 105 (7): 863–75. doi:10.1016/S0092-8674(01)00396-8. PMID 11439183.
- Mukerjee N, McGinnis KM, Gnegy ME, Wang KK (August 2001). “Caspase-mediated calcineurin activation contributes to IL-2 release during T cell activation”. Biochemical and Biophysical Research Communications. 285 (5): 1192–9. doi:10.1006/bbrc.2001.5278. PMID 11478781.
- Volkel H, Scholz M, Link J, Selzle M, Werner P, Tunnemann R, Jung G, Ludolph AC, Reuter A (August 2001). “Superoxide dismutase mutations of familial amyotrophic lateral sclerosis and the oxidative inactivation of calcineurin”. FEBS Letters. 503 (2–3): 201–5. doi:10.1016/S0014-5793(01)02730-2. PMID 11513882.
- Esau C, Boes M, Youn HD, Tatterson L, Liu JO, Chen J (November 2001). “Deletion of calcineurin and myocyte enhancer factor 2 (MEF2) binding domain of Cabin1 results in enhanced cytokine gene expression in T cells”. The Journal of Experimental Medicine. 194 (10): 1449–59. doi:10.1084/jem.194.10.1449. PMC 2193671. PMID 11714752.
- Frey N, Olson EN (April 2002). “Calsarcin-3, a novel skeletal muscle-specific member of the calsarcin family, interacts with multiple Z-disc proteins”. The Journal of Biological Chemistry. 277 (16): 13998–4004. doi:10.1074/jbc.M200712200. PMID 11842093.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH